Market revenue in 2023 | USD 7.2 million |
Market revenue in 2030 | USD 15.5 million |
Growth rate | 11.5% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.33% in 2023. Horizon Databook has segmented the Malaysia deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Malaysia, being a developing country, began its movement disorder program for PD affected patients by undertaking ablation therapy using radionics system (electromagnetic therapy). Furthermore, after the increase in awareness among individuals and healthcare professionals, long-term benefits of deep brain stimulation was evaluated.
Some of the companies operating in deep brain stimulation segment are Medtronic and Boston Scientific Medical Device. Thus, presence of companies and increase in awareness programs are expected to drive the growth of deep brain stimulation devices market in Malaysia.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account